These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4087966)

  • 1. [Gaucher disease: clinical manifestations of 6 cases].
    Mora P; Arnalich F; Fuentes E; Barbado J; del Rey R; Vázquez JJ
    Med Clin (Barc); 1985 Dec; 85(20):819-22. PubMed ID: 4087966
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathology of Gaucher disease.
    Lee RE
    Prog Clin Biol Res; 1982; 95():177-217. PubMed ID: 7122634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients.
    Kolodny EH; Ullman MD; Mankin HJ; Raghavan SS; Topol J; Sullivan JL
    Prog Clin Biol Res; 1982; 95():33-65. PubMed ID: 6289358
    [No Abstract]   [Full Text] [Related]  

  • 4. Oculomotor deficits in Gaucher disease.
    Stowens DW; Chu FC; Cogan DG; Barranger JA
    Prog Clin Biol Res; 1982; 95():143-7. PubMed ID: 7122632
    [No Abstract]   [Full Text] [Related]  

  • 5. Gaucher disease of the Norrbottnian type (type III). Phenotypic manifestations.
    Svennerholm L; Dreborg S; Erikson A; Groth CG; Hillborg PO; Håkansson G; Nilsson O; Tibblin E
    Prog Clin Biol Res; 1982; 95():67-94. PubMed ID: 6812091
    [No Abstract]   [Full Text] [Related]  

  • 6. Gaucher disease: hepatic abnormalities in 25 patients.
    James SP; Stromeyer FW; Stowens DW; Barranger JA
    Prog Clin Biol Res; 1982; 95():131-42. PubMed ID: 7122631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P; Andersson HC; Kacena KA; Yee JD
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and enzyme studies in Gaucher disease.
    Kaur M; Kabra M; Kher A; Naik G; Bharucha BA; Verma IC
    Indian Pediatr; 1996 Sep; 33(9):735-8. PubMed ID: 9057400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presenting signs and symptoms in Gaucher disease].
    Erdös M; Tóth J; Maródi L
    Orv Hetil; 2002 Oct; 143(41):2327-35. PubMed ID: 12434734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease: a century of delineation and understanding.
    Desnick RJ
    Prog Clin Biol Res; 1982; 95():1-30. PubMed ID: 6750651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and morphological study on 2 cases of Gaucher's disease in 2 subjects from the same family].
    Ferreli A; Valdès E; Silvetti M; Biddau P
    Arch De Vecchi Anat Patol; 1973 Sep; 59(1):1-30. PubMed ID: 4804229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gaucher's disease. Longitudinal-study in 17 patients in a 10-year period (1970-1980) (author's transl)].
    Di Rocco M; Salemi D; Borrone C
    Pediatr Med Chir; 1981; 3(6):487-94. PubMed ID: 7343946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease and dysgammaglobulinemia: a report of 61 patients, including 18 with GD type III.
    Jurecka A; Gregorek H; Kleinotiene G; Czartoryska B; Tylki-Szymanska A
    Blood Cells Mol Dis; 2011 Jan; 46(1):85-7. PubMed ID: 20729110
    [No Abstract]   [Full Text] [Related]  

  • 14. South African variants of Gaucher disease.
    Goldblatt J; Beighton P
    Prog Clin Biol Res; 1982; 95():95-106. PubMed ID: 7122645
    [No Abstract]   [Full Text] [Related]  

  • 15. Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy.
    Grosbois B; Rose C; Noël E; Serratrice Cde R; Dobbelaere D; Gressin V; Chérin P; Hartmann A; Javier RM; Clerson P; Hachulla E; Jaussaud R;
    Blood Cells Mol Dis; 2009; 43(1):138-9. PubMed ID: 19427246
    [No Abstract]   [Full Text] [Related]  

  • 16. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
    Horovenko NH; Drozdova VD; Nedoboĭ AM; Ol'khovych NV; Pichkur NO; Tsyhankova MA; Radzikhovs'ka OV
    Tsitol Genet; 2006; 40(3):67-71. PubMed ID: 16933855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
    J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical aspects of chronic Gaucher's disease.
    Matoth Y; Zaizov R; Hoffman J; Klibansky C
    Isr J Med Sci; 1974 Dec; 10(12):1523-9. PubMed ID: 4443228
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical diversity in Gaucher's disease.
    Sack GH
    Johns Hopkins Med J; 1980 Apr; 146(4):166-70. PubMed ID: 7366062
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of cardiopulmonary involvement in Gaucher's disease.
    el Gawhary S; Omran S; Sharaf-Eddine I
    Tunis Med; 1999 Jan; 77(1):12-8. PubMed ID: 10333691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.